Project TRUST
Existing Patients
Make an appointment by phone
617.680.1828
Make an appointment with MyChart
Book with MyChart
New Patients
If you are a new patient and need an appointment, please contact us at the phone number below.
Learn more about coming to BMC. 617.680.1828Refer a Patient
Refer a patient
Call for assistance with the referral process
617.680.1828
Project TRUST’s goal is to help anyone who is actively struggling with substance use access comprehensive and compassionate care without judgement. We provide addiction treatment resources, harm reduction education and supplies, and navigation to an array of medical services including primary care and urgent care services. The Project TRUST team is made up of compassionate community health workers, who use their lived experience to guide people in active addiction. The Project TRUST drop-in was started in 1988 in response to the first wave of HIV in Boston among persons who use injection drugs. We have continued with our mission to provide comprehensive services that stop the transmission of infectious diseases in those who struggle with substance use.
Contact Us
721 Massachusetts Avenue, Boston, MA 02118
Conditions We Treat
Research Overview
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report. - Harris M, Johnson S, Mackin S, Saitz R, Walley AY, Taylor JL. J Addict Med. 2020;14(4):e136-e138. doi:10.1097/ADM.0000000000000682
Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment - Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM. [published online ahead of print, 2021 Jun 22]. J Gen Intern Med. 2021;1-10. doi:10.1007/s11606-021-06904-4
Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital. - Burns RH, Pierre CM, Marathe JG, et al. Open Forum Infect Dis. 2021;8(8):ofab208. Published 2021 Apr 27. doi:10.1093/ofid/ofab208
Residency and Fellowship Information
Addiction Medicine Fellowship
The mission of the Grayken Fellowship in Addiction Medicine is to train physician addiction medicine leaders in clinical care, research, education, public health, and advocacy to improve addiction care for people vulnerable to health inequities due to race, ethnicity, gender, poverty, age, disability or stigmatizing illness.
The Grayken Addiction Medicine Fellowship Program is a 1 or 2 year fellowship. There is also a 3-year combined Infectious Disease-Addiction Medicine Fellowship and a 2-year Fellowship in Maternal Health Addiction. Fellows are mentored by our multidisciplinary faculty from Internal Medicine, Infectious Disease, Emergency Medicine, Obstetrics & Gynecology and Addiction Psychiatry. The Grayken Fellowship in Addiction Medicine is accredited by the ACGME. Click here to learn more
Latest from HealthCity
Rapid ACCESS Is Filling the Gaps for Patients With Addiction
The program's recovery coaches meet patients where they are and help them navigate services to suit their individual needs.
One Addiction Counselor's Life Mission to Assist Others in Recovery
A licensed alcohol and drug counselor explores how her own experience in recovery helps her as she walks alongside others on a similar path.
It's Our Responsibility to Treat the Human Suffering at Heart of Opioid Overdose Crisis
Data shows that overdose deaths have reached staggering heights. The healthcare system should respond with a person-centered, racial-justice approach.
Making the Case for Employer-Sponsored Addiction Treatment
In a hypothetical firm of 10,000 employees, researchers estimated $232,000 of lost wage value annually due to SUD-related absenteeism.
How to Close the Racial Disparity Gap in HIV Diagnoses and Treatment
Compassionate, culturally competent care for preventing HIV reduces infection rates in marginalized communities.
Checking Arrest Warrants Undermines the Goal of Post-Overdose Outreach Visits
To better engage overdose survivors and remove barriers to treatment, research suggests that outreach programs consider limiting the practice.
New Findings Point to a Promising HIV Vaccine Research Path
The immune response known as ADCC is associated with protection against transmission of the virus, research from BMC shows.
Safe Consumption Sites Directly Meet the Needs of the BMC Community
Grayken Center for Addiction staff testified to the state on the need for safe consumption sites to address opioid overdose deaths.
Disparities in Opioid Overdose Deaths Are Worsening for Black Americans
HEALing Communities Study data underscores the need for racially inclusive approaches to address the opioid epidemic in vulnerable neighborhoods.
A Massachusetts Study Aims to Reduce Opioid Overdose Deaths
The HEALing Communities Study is up and running in several cities, bringing opioid use disorder treatment to people where they are.
Emergency Departments Have an Opportunity to Boost HIV Testing
To quell a rising epidemic, BMC has embedded HIV counselors in the ED to increase declining testing rates and connect people to effective treatment.
People Who Inject Drugs Need Accessible PrEP, MOUD Information
A study reveals that people at a drug detoxification site were unaware of HIV pre-exposure prophylaxis, or PrEP, but were enthusiastic when informed.
